Alumis Inc
Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company's clinical asset comprises ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor for neuroinfl… Read more
Alumis Inc (ALMS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.288x
Based on the latest financial reports, Alumis Inc (ALMS) has a cash flow conversion efficiency ratio of -0.288x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-110.91 Million) by net assets ($384.77 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Alumis Inc - Cash Flow Conversion Efficiency Trend (2022–2024)
This chart illustrates how Alumis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Alumis Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alumis Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Penn National Gaming Inc
NASDAQ:PENN
|
0.059x |
|
China Nonferrous Mining Corporation Limited
STU:3N4
|
0.072x |
|
Cholamandalam Financial Holdings Limited
NSE:CHOLAHLDNG
|
-0.369x |
|
PT Barito Pacific Tbk
F:OB8
|
-0.007x |
|
Summerset Group Holdings Limited
PINK:SMGRF
|
0.026x |
|
H2O America
NASDAQ:HTO
|
0.051x |
|
Netcompany Group A/S
OTCQX:NTCYF
|
0.114x |
|
Integral Ad Science Holding LLC
NASDAQ:IAS
|
0.044x |
Annual Cash Flow Conversion Efficiency for Alumis Inc (2022–2024)
The table below shows the annual cash flow conversion efficiency of Alumis Inc from 2022 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $260.10 Million | $-255.08 Million | -0.981x | -355.98% |
| 2023-12-31 | $-339.26 Million | $-129.97 Million | 0.383x | -30.56% |
| 2022-12-31 | $-195.24 Million | $-107.72 Million | 0.552x | -- |